Literature DB >> 17483139

Weekly versus basic smoking cessation support in primary care: a randomised controlled trial.

Paul Aveyard1, Karen Brown, Cas Saunders, Avril Alexander, Elaine Johnstone, Marcus R Munafò, Mike Murphy.   

Abstract

BACKGROUND: There is insufficient and conflicting evidence about whether more intensive behavioural support is more effective than basic behavioural support for smoking cessation and whether primary care nurses can deliver effective behavioural support.
METHODS: A randomised controlled trial was performed in 26 UK general practices. 925 smokers of >or=10 cigarettes per day were randomly allocated to basic or weekly support. All participants were seen before quitting, telephoned around quit day, and seen 1 and 4 weeks after the initial appointment (basic support). Participants receiving weekly support had an additional telephone call at 10 days and 3 weeks after the initial appointment and an additional visit at 2 weeks to motivate adherence to nicotine replacement and renew quit attempts. 15 mg/16 h nicotine patches were given to all participants. The outcome was assessed by intention to treat analyses of the percentage confirmed sustained abstinence at 4, 12, 26 and 52 weeks after quit day.
RESULTS: Of the 469 and 456 participants in the basic and weekly arms, the numbers (%) who quit and the percentage difference were 105 (22.4%) vs 102 (22.4%), 0.1% (95% CI -5.3% to 5.5%) at 4 weeks, 66 (14.1%) vs 52 (11.4%), -2.6% (95% CI -6.9% to 1.7%) at 12 weeks, 50 (10.7%) vs 40 (8.8%), -1.9% (95% CI -5.7% to 2.0%) at 26 weeks and 36 (7.7%) vs 30 (6.6%), -1.1% (95% CI -4.4% to 2.3%) at 52 weeks.
CONCLUSIONS: The absolute quit rates achieved are those expected from nicotine replacement alone, implying that neither basic nor weekly support were effective. Primary care smoking cessation treatment should provide pharmacotherapy with sufficient support only to ensure it is used appropriately, and those in need of support should be referred to specialists.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483139      PMCID: PMC2094265          DOI: 10.1136/thx.2006.071837

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  20 in total

Review 1.  A meta-analysis of the efficacy of over-the-counter nicotine replacement.

Authors:  J R Hughes; S Shiffman; P Callas; J Zhang
Journal:  Tob Control       Date:  2003-03       Impact factor: 7.552

Review 2.  Have we lost our way? The need for dynamic formulations of smoking relapse proneness.

Authors:  Thomas M Piasecki; Michael C Fiore; Danielle E McCarthy; Timothy B Baker
Journal:  Addiction       Date:  2002-09       Impact factor: 6.526

Review 3.  Shape of the relapse curve and long-term abstinence among untreated smokers.

Authors:  John R Hughes; Josue Keely; Shelly Naud
Journal:  Addiction       Date:  2004-01       Impact factor: 6.526

Review 4.  Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.

Authors:  Fujian Song; James Raftery; Paul Aveyard; Chris Hyde; Pelham Barton; Nerys Woolacott
Journal:  Med Decis Making       Date:  2002 Sep-Oct       Impact factor: 2.583

5.  Withdrawal-oriented therapy for smokers.

Authors:  P Hajek
Journal:  Br J Addict       Date:  1989-06

6.  Randomised trial of nicotine patches in general practice: results at one year. Imperial Cancer Research Fund General Practice Research Group.

Authors: 
Journal:  BMJ       Date:  1994-06-04

7.  Effects of nicotine chewing gum and follow-up appointments in physician-based smoking cessation.

Authors:  K O Fagerström
Journal:  Prev Med       Date:  1984-09       Impact factor: 4.018

8.  Smoking cessation guidelines for health professionals: an update. Health Education Authority.

Authors:  R West; A McNeill; M Raw
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

9.  Treatment for cigarette smoking in a Department of Veterans Affairs outpatient clinic.

Authors:  J L Weissfeld; J L Holloway
Journal:  Arch Intern Med       Date:  1991-05

10.  Measures of abstinence in clinical trials: issues and recommendations.

Authors:  John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2003-02       Impact factor: 4.244

View more
  39 in total

1.  Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Marco F Ramoni; Frederique M Behm; Jed E Rose
Journal:  Mol Med       Date:  2010-08-24       Impact factor: 6.354

2.  Predictors of adherence to nicotine gum and counseling among African-American light smokers.

Authors:  Kolawole S Okuyemi; Hui Zheng; Hongfei Guo; Jasjit S Ahluwalia
Journal:  J Gen Intern Med       Date:  2010-05-21       Impact factor: 5.128

Review 3.  Managing smoking cessation.

Authors:  Paul Aveyard; Robert West
Journal:  BMJ       Date:  2007-07-07

4.  Interventions to increase adherence to medications for tobacco dependence.

Authors:  Gareth J Hollands; Felix Naughton; Amanda Farley; Nicola Lindson; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2019-08-16

5.  Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

Authors:  Sean P David; Elaine C Johnstone; Michael F G Murphy; Paul Aveyard; Boliang Guo; Caryn Lerman; Marcus R Munafò
Journal:  Drug Alcohol Depend       Date:  2008-06-17       Impact factor: 4.492

6.  CHRNA3 rs1051730 genotype and short-term smoking cessation.

Authors:  Marcus R Munafò; Elaine C Johnstone; Donna Walther; George R Uhl; Michael F G Murphy; Paul Aveyard
Journal:  Nicotine Tob Res       Date:  2011-06-20       Impact factor: 4.244

Review 7.  Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.

Authors:  Sean P David; Elaine C Johnstone; Michael Churchman; Paul Aveyard; Michael F G Murphy; Marcus R Munafò
Journal:  Nicotine Tob Res       Date:  2011-01-25       Impact factor: 4.244

8.  Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial.

Authors:  Babalola Faseru; Nicole L Nollen; Matthew S Mayo; Ron Krebill; Won S Choi; Neal L Benowitz; Rachel F Tyndale; Kolawole S Okuyemi; Jasjit S Ahluwalia; Lisa Sanderson Cox
Journal:  Addict Behav       Date:  2012-11-29       Impact factor: 3.913

9.  Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.

Authors:  Theresa M Marteau; Marcus R Munafò; Paul Aveyard; Chloe Hill; Sophia Whitwell; Thomas A Willis; Rachel A Crockett; Gareth J Hollands; Elaine C Johnstone; Alison J Wright; A Toby Prevost; David Armstrong; Stephen Sutton; Ann Louise Kinmonth
Journal:  BMC Public Health       Date:  2010-11-09       Impact factor: 3.295

10.  Rapid reduction versus abrupt quitting for smokers who want to stop soon: a randomised controlled non-inferiority trial.

Authors:  Nicola Lindson; Paul Aveyard; Jackie T Ingram; Jennie Inglis; Jane Beach; Robert West; Susan Michie
Journal:  Trials       Date:  2009-08-14       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.